The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.
By Brad Spellberg, Robert J Guidos, David N. Gilbert, John S. Bradley, Helen W. Boucher, W. M. Scheld, John G. Bartlett, John E. Edwards. Clinical Infectious Diseases, 2008
959 citations recorded by the source corpus.
Subfields: Agronomy and Crop Science, Infectious Diseases, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/2c5a37970d9cfded576a5c2354f04555b384ccef
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
Citations in the corpus
- Antibiotics in the aquatic environments: A review of the European scenario. (2016, positive): “…and encouragement measures on research and development of new antibiotic agents with a novel mechanism of action are crucial to protect animal and human against antibiotic-resistant infections (Payne and Tomasz, 2004; Overbye and Barrett, 2005; Spellberg et al., 2008; Cruickshank et al., 2014).”
- The global threat of antimicrobial resistance: science for intervention (2015, neutral): “As stated above, antibiotic abuse has greatly contributed to speed up the development of antibiotic resistance, and in this regard human medicine has played a key role [11].”
- Antibiotics and Bacterial Resistance in the 21st Century (2014, neutral): “Penicillins Penicillin binding proteins Penicillin G (4) and V, ampicillin (7), ampicillin (7) / sulbactam (22), amoxicillin (8), amoxicillin (8) / clavulanate, piperacillin (9), piperacillin (9) / tazobactam (21), azlocillin, carbenacillin, mezlocillin, ticarcillin, ticarcillin / clavulanate”
- Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. (2009, positive): “In-deed In-deed, we found a 75% decrease in systemic antibacterials approved by the FDA from 1983 through 2007, with evidence of continued decrease in approvals, even during the most recent 5-year period (2003–2007) [3].”